Barriers and Facilitators for Medication Adherence in Stroke Patients: A Qualitative Study Conducted in French Neurological Rehabilitation Units
Barriers and Facilitators for Medication Adherence in Stroke Patients: A Qualitative Study Conducted in French Neurological Rehabilitation Units
复制标题
DOI：
10.1159/000362718
复制
发表时间：
2014-01-01
影响因子：
2.4
通讯作者：
Janoly-Dumenil, Audrey
中科院分区：
文献类型：
--
作者：
Bauler, Stephanie;Jacquin-Courtois, Sophie;Janoly-Dumenil, Audrey
目的：描述法国患者，护理人员和医疗保健专业人员对中风和二级预防药物的看法。方法：以脑卒中、二级预防药物、患者经历、患者/护理者与医疗团队关系四个预定主题为基础，进行定性研究。结果：共进行了26次访谈。服药困难、对中风和药物益处缺乏了解、对药物过量的恐惧被认为是患者坚持服药的障碍。护理人员表达了对仿制药的怀疑。卫生保健专业人员报告说，缺乏知识和没有临床症状是障碍。另一方面，来自护理人员和医疗保健专业人员的支持对于所有参与者的依从性至关重要。患者和护理人员表示，对复发的恐惧是治疗依从性的促进因素。结论：本研究强调了卒中治疗依从性的障碍和促进因素，并强调了患者、护理人员和医疗保健专业人员之间的看法的异同。这些结果必须纳入法国未来的教育计划，以提高药物依从性。(C) 2014 S. Karger AG，巴塞尔
Objective: To describe the perceptions of French patients, caregivers and healthcare professionals on stroke and secondary preventive medications. Method: A qualitative study was conducted, based on four predetermined topics: stroke, secondary prevention medications, patient's experience, relationship between patient/caregiver and healthcare team. Results: Twenty-six interviews were conducted. Difficulties in taking medications, lack of knowledge on stroke and medication benefits, fear of overmedication were identified as barriers for adherence in patients. Doubts about generic drugs were expressed by caregivers. Healthcare professionals reported lack of knowledge and absence of clinical symptoms as barriers. On the other hand, support from caregivers and healthcare professional support is essential for compliance in all participants. Patients and caregivers expressed that fear of recurrence was a facilitator for treatment compliance. Conclusion: This study highlights the barriers and facilitators for stroke treatment adherence and underlines the similarities and differences between the perceptions of patients, caregivers and healthcare professionals. These results must be integrated into the future French educational programs to improve medication adherence. (C) 2014 S. Karger AG, Basel